A novel magnetobiosensing approach for the rapid and simultaneous detection of two breast cancer-related miRs (miR-21 and miR-205) is reported. It involves the use of antimiR-21 and antimiR-205 specific probes, chitin-modified magnetic beads (Chitin-MBs), the p19 viral protein as capture bioreceptor and amperometric detection with the H 2 O 2 /hydroquinone (HQ) system at dual screen-printed carbon electrodes (SPCEs). The use of dual SPCEs allows the simultaneous independent amperometric readout for each target miR to be measured. The magnetosensor exhibited sensitive and selective detection of both target miRs with a dynamic range from 2.0 to 10.0 nM and detection limits of 0.6 nM (6 fmol) for both target miRs without any amplification step in less than 2 h. The usefulness of the approach was evaluated by detecting the endogenous levels of both target miRs in total RNA (RNA t ) extracted from metastatic breast cancer cell lines and human tissues.
Introduction
Breast cancer is the most prevalent cancer and the second leading cause of cancer death in women. Like many cancers, breast cancer is a heterogeneous disease that differs molecularly, biologically and clinically. Breast cancer is commonly classified by the estrogen/progesterone (ER/PR) receptor status and the HER2 (ERBB2) amplification status. Breast cancers that are ER+ and or PR+ are treatable with hormonal therapies, while patients having HER2 amplification respond to receptor tyrosine kinase inhibitors. Triple-negative breast cancer (TNBC) represents around 10-20% of breast cancers and is defined by the absence of ER and PR expression and HER2 amplification. The TNBC patients have the worse prognosis because of the lack of effective targeted therapeutics. Successful treatments for these patients may be possible once the molecular basis of this aggressive phenotype is better understood (Elgamal et al., 2013) . Moreover, although tumor markers greatly improve cancer diagnosis, the invasive, unpleasant, and inconvenient nature of current diagnostic procedures limits their application. Hence, there is a great need for identification of novel non-invasive biomarkers for early tumor detection (Chen et al., 2008) . miRNAs (or miRs) are endogenously processed non-coding RNAs of 19-25 nucleotides in length, which control gene expression by targeting mRNAs and triggering either translation repression or RNA degradation. Since their discovery, they have been found to play a role in almost all critical biological processes in cells such as differentiation, proliferation, stress response or apoptosis. Growing evidences suggest that miRs could emerge as revolutionary biomarkers in the cancer field for the diagnosis, prognosis or treatment efficacy. Highthroughput profiling of miRs from cancer patients in several types of cells and tissues found that signature groups or 'clusters' of miRs have consistently increased or decreased expression levels when compared to normal tissues, exerting oncogenic or tumor suppressor activity (Bartosik et al., 2014) . Although single miRs have been associated with a wide variety of disease conditions and can target multiple mRNAs, several miRs may be simultaneously involved in disease progression and development (Ban et al., 2013) . The profiling of different miR types in parallel is important for a comprehensive cancer classification, especially in the case of very heterogeneous cancers-like lymphomas.
Consequently, the simultaneous detection of different miRs expression at a single time might allow a more accurate characterization of different tumor subtypes (Zhang et al., 2007) (Weishaupt et al., 2013) . However, several intrinsic characteristics of miRs such as their short sequence length, low abundance and high sequence similarity between miR family members, make their detection a challenging task (Dong et al., 2014) . Currently, miRs are detected by expensive, complicated and time consuming techniques such as Northern blot, reverse transcription polymerase chain reaction (RT-PCR), microarrays and RNA sequencing (Lusi et al., 2009) which are not ideally compatible with portable point-of-care devices. Therefore, the development of methods capable to measure miRs in a reliable manner with high specificity and sensitivity but also complying the requirements for minute sample volume, costeffectiveness and multiplexing capability, are highly desired.
In this context, electrochemical nucleic acid biosensors have emerged as particularly attractive options for miRs detection in terms of sensitivity, simplicity of use and automation, short assay time, low detection limit, small amount of sample required, non-toxic experimental steps and adaptability to point-of-care testing, (Ramnani et al., 2013) .
As miRs represent only a very small fraction (ca. 0.01%) of total RNA mass (Krol et al., 2010) , it is important to note that any hybridization based-methods bear the limitation of potential hybridization of the probe with other RNA. Possible interferences in the detection of a mature miR include pri-miR, pre-miR and the longer intermediates of miR biogenesis which possess the sequence motifs of the mature miR. One ingenious way to overcome this problem has been reported through the use of electrochemical sensors based on p19 RNA binding protein (Kilic et al., 2013) , (Labib et al., 2013 a ), , (TorrenteRodríguez et al, 2014) which behaves like a molecular caliper of small double-stranded RNA (21-23 base pairs) and sequesters miRs in a size dependent, sequence-independent manner.
Thus besides ruling out other nucleotides including single stranded RNA (ssRNA), ssDNA, and dsDNA, a size selectivity for dsRNA in the size range of miRs is achieved.
Magnetobiosensors have demonstrated also to be promising approaches for the detection of specific miRs (Betazzi et al., 2013) , (Bartosik et al., 2014) , , . Despite the increasing number of promising electrochemical sensors described for miRs determination, to our knowledge, none of them allows the simultaneous detection of different miRs in a single test.
Recently two relevant miRs have been shown to be associated with breast cancer: miR-21 and miR-205. In particular, miR-21 acts as a non-specific oncogene and affects tumor invasion and inhibits tumor cell colonization. MiR-205 is a breast cancer specific tumor suppressor involved in angiogenesis (Markou et al., 2014) . MiR-205 is also a direct target of the tumor suppressive transcription factor p53, and decreased expression of miR-205 is common in TNBC cells that are frequently p53 deficient (Wang and Lin, 2013) (Savad et al., 2012) . These findings highlight that simultaneous interrogation of miR-21 and miR-205 will allow the unequivocal identification of breast cancer groups (not possible with individual detection of miR-205) making it possible the discrimination between the TNBC group and the others.
In this work, we describe the first electrochemical magnetosensor to simultaneously detect the expression of two different miRs in one single experiment. The implemented methodology involved the use of magnetic beads, specific biotinylated antimiR probes, the p19 viral protein and amperometric detection at dual SPCEs using the HQ/HRP/H 2 O 2 system. Once the dual magnetosensor performance was evaluated, it was successfully applied to the detection of both endogenous miRs in cultured breast cancer cells and human tissues from real breast cancer patients.
Materials and Methods
Details about apparatus, electrodes, reagents and solutions and all the protocols used (hybridization, MBs modification, sample analysis and amperometric measurements) are described in detail in the Supporting Information.
Results and discussion
The fundamentals of the simultaneous determination of miR-21 and miR-205 using the disposable dual electrochemical magnetosensor are displayed in Fig. 1a . In brief, p19 was The working variables used (summarized in Table S2 in the Supporting Information) were the same than those optimized for the magnetosensor constructed for the individual detection of miR-21 . It is worth to mention that hybridization between the specific biotinylated antimiR probe and the target miR was carried out at 25 °C and only for methodologies.
The possible cross-talking between the adjacent working electrodes is considered as a potential major drawback to be solved in the design of electrochemical multisensory platforms because it would lead to false results (Escamilla-Gómez et al., 2009 ). were mostly due to the selective binding of the RNA duplexes to the p19 protein, thus demonstrating the potentially of the approach for miR determination.
Analytical characteristics
The reproducibility of the responses obtained for 5 nM of both miRs with different dual magnetosensors constructed using the same protocol was tested. , this can be attributed to the remarkably smaller active surface area of the commercial dual SPCEs working electrodes when compared with the single SPCEs (6.3 vs. 12.6 mm 2 ). However, it is important to remark that the LODs achieved with the dual magnetosensor are sufficient to allow the detection of target miRs in tumor breast cells and tissues as it will be shown below.
In addition, the analytical characteristics provided by the dual magnetosensor were also compared with the reported data for other electrochemical sensors used for miRs determination (Table 1) . It can be deduced that the achieved LODs are higher than those reported using approaches involving multiple reagents and complex and time consuming working protocols including amplification strategies (Pöhlmann and Sprinzl., 2010) , (Yin et al., 2012) , (Labib et al., 2013 b ), (Betazzi et al., 2013) , (Meng et al., 2013) , (Wen et al., 2013) , (Li et al., 2014) , (Yang et al., 2014) . The LODs are also higher than that reported by Betazzi et al. for miR-222 involving biotinylated RNA capture probes immobilized on streptavidincoated paramagnetic beads and previous labeling with biotin (Betazzi et al., 2013) , but are better than that reported by Bartosik et al. for miR-522 using a similar strategy with labeling of the target miR with an electroactive osmium(VI) complex (Bartosik et al., 2014) . Besides the LOD values, it is important to mention that the approach reported here did not require previous target labeling to perform the determination which constitutes a very important practical advantage.
Selectivity
Due to the sequence homology of miR family members, a significant challenge in their analysis is achieving differentiation of the target miRs from other miRs and detect them selectively even in complex mixtures. The selectivity of the dual amperometric magnetosensor was investigated by comparing the current values measured for the blank, synthetic targets, sequences with only one central base mismatched (1-m) with respect to the target miRs (based underlined in Table S1 ), fully non-complementary (NC) sequences and mixtures of the NC sequences containing or not the synthetic targets (each at a concentration of 5 nM). Apart from miR-21 in the case of miR-205 detection and vice versa, miR-192 was assayed as the NC sequence because it also appears up regulated in breast cancer patients (Wu et al., 2011) but its sequence differs markedly from that of the target miRs. Fig. 3 shows the obtained results. When the NC sequences, or a mixture of them, were assayed, current values similar to that of the blank were measured (red, black and yellow bars in Fig. 3 ). Moreover, an acceptable discrimination between the target miRs and the corresponding 1-m sequences was also observed. Assuming 100 % complementary hybridization efficiency for each target miR, this efficiency dropped to approximately 86 % for the 1-m sequences (green bars in Fig.   3 ). Additional studies showed that discrimination towards the corresponding 1-m sequences could be improved reducing their signal to 62 % of that corresponding to the target miRs by performing the hybridization at the melting temperature of each target miR, which is in agreement with data reported previously (Bartosik et al., 2014) . On the other hand, the mixtures containing the target miR and the NC sequences (blue bars in Fig. 3 ) provided amperometric responses similar to those measured for the target miR alone. These results demonstrated the high selectivity of the approach to discriminate the target miR over other non-targeted miRs, which allowed their detection in raw RNA t extracted from cell lines and breast-cancer tissue samples where other non target miRs are present in a large extent.
Detection of miR-21 and miR-205 in RNA t extracted from breast cancer cells and tumor tissues
Given the undeniable value of detecting miR-21 and miR-205 expression levels in breast cancer tissues, the usefulness of the developed methodology for the simultaneous detection of these target miRs in RNA t extracted from breast-cancer cells and human tissues was verified.
The methodology was applied to three different metastatic breast-cancer cell lines: MCF-7 (an ER+/PR+ cell line), SK-BR-3 (an ER-/PR-cell line) and MDA-MB-231 (a TNBC cell line) as well as to primary epithelial nontumorigenic cells (MCF-10A) with no detectable amount of miR-21 (Ribas et al., 2013) , (Elgamal et al., 2013) . (Ribas et al., 2013) , , (Elgamal et al., 2013) . Moreover, the magnetogenosensor response to miR-205 was higher for MCF-7 than for MDA-MB-231 and SK-BR-3 cells which is in agreement with the specificity of miR-205 to ER/PR status, showing higher expression in ERα+/ PR+ with respect to ER-/PR-receptor profile (Mattie et al., 2006) . The same methodology was also applied to the detection of both miRs in RNA t extracted from human breast tissues. RNA t was extracted from tumor (T) and paired normal adjacent tissues (NT) from different breast cancer patients. Similarly (Fig. 4a, right) , and in agreement also with previous findings, while miR-21 was highly overexpressed in breast tumor tissues compared to the matched normal breast tissues (Si et al., 2007) , miR-205 was underexpressed in T tissues (Singh and Mo, 2013) . It is worth to mention that Fig. 4a shows only one datum for normal tissues because there were not significant differences between the current values measured for both miRs in this kind of samples. Moreover, the miR-21 overexpression levels observed in tumor tissues were, in all cases, in good agreement with the overexpression ratios range (1.557−2.449) reported by Savad et al. (Savad et al., 2012) in tissues from different breast cancer groups.
Lastly, in order to evaluate the possibility of reducing drastically the assay time, the performance of the methodology was tested by shortening considerably each step involved,
i.e., 1) homogeneous hybridization between the target miRs and the antimiR probes (30 min),
2) capture of the dsRNAs by the p19-MBs (60 min) and 3) labeling of the captured dsRNA with Strep-HRP (15 min). The three steps were shortened to only 5 min, thus reducing the total assay time from 105 to 15 min. Interestingly, Figure 5 shows that although, as expected, the sensitivities were smaller (∼2 times lower for both miRs), the obtained amperometric responses were still sufficiently large to discriminate clearly between up regulated and normal mature miR levels. This relevant result outlined the potentiality of the developed methodology to be employed as a rapid method for alarm or screening purposes able to discriminate tumoral vs. non-tumoral tissues.
Conclusions
We report in this work the first disposable amperometric magnetosensor for the simultaneous detection of miR-21 and miR-205 making it possible to match the clinically relevant concentration ranges of both cancer biomarkers. The dual amperometric magnetosensor exhibits excellent analytical performance and was employed successfully to measure the endogenous levels of both target miRs directly in RNA t raw samples extracted from breastcancer cell lines and human breast-tumor specimens without prior amplification, preconcentration or purification steps in about 2 h. These results suggest that the simultaneous detection of multiple miRNAs is possible through a combination of multiplexed detection and different RNA probes. Although this paper is focused only on two specific miRNAs, the presented methodology could be easily extended to the simultaneous profiling of multiple 
Highlights:
Ͳ First amperometric magnetosensor for simultaneous detection of two miRs.
Ͳ Detection limits of 0.6 nM (6 fmol) without any amplification step in less than 2 h.
Ͳ Successful detection in breast cancer cell lines and human tissues.
Ͳ Methodology easily extended to the simultaneous profiling of multiple miRs.
Ͳ Potential applications in cancer research and clinical diagnosis. 
